German High-Grade Non-Hodgkin's Lymphoma Study Group Report issue

Academic/Hospital Phase 2 Phase 3
Founded: Leipzig Germany (1993)

Organization Overview

First Clinical Trial
2001
NCT00052936
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2011

Timeline

NOW
  • Now

Alternative names

German High Grade Non Hodgkin´s Lymphoma Study Group

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Aggression (Phase 3)

Immunoblastic Lymphadenopathy (Phase 3)

Lymphadenopathy (Phase 3)

Lymphoma (Phase 3)

Lymphoma, B-Cell (Phase 3)

Lymphoma, Extranodal NK-T-Cell (Phase 3)

Lymphoma, Non-Hodgkin (Phase 3)

Lymphoma, T-Cell (Phase 3)

Lymphoma, T-Cell, Peripheral (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 10
  • # of Trial APIs: 11